| Dasatinib induces severe hemorrhagic colitis in a patient with accelerated phase of chronic myelogenous leukemia |
|
Yim, Eunjung
(Department of Internal Medicine, College of Medicine, The Catholic University of Korea)
Choi, Yeon-Geun (Department of Internal Medicine, College of Medicine, The Catholic University of Korea) Nam, Yoon-Jeong (Department of Internal Medicine, College of Medicine, The Catholic University of Korea) Lee, Jain (Department of Internal Medicine, College of Medicine, The Catholic University of Korea) Kim, Jeong-A (Department of Internal Medicine, College of Medicine, The Catholic University of Korea) |
| 1 | Talpaz M, Shah NP, Kantarjian H, et al. Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias. N Engl J Med 2006;354:2531-2541. DOI |
| 2 | Kostos L, Burbury K, Srivastava G, Prince HM. Gastrointestinal bleeding in a chronic myeloid leukaemia patient precipitated by dasatinib-induced platelet dysfunction: case report. Platelets 2015;26:809-811. DOI |
| 3 | Gratacap MP, Martin V, Valera MC, et al. The new tyrosine- kinase inhibitor and anticancer drug dasatinib reversibly affects platelet activation in vitro and in vivo. Blood 2009;114:1884-1892. DOI |
| 4 | Kmira Z, Nesrine BS, Houneida Z, et al. Severe hemorrhagic colitis in a patient with chronic myeloid leukemia in the blastic phase after dasatinib use. World J Gastrointest Pathophysiol 2013;4:59-62. DOI |
| 5 | Quintas-Cardama A, Han X, Kantarjian H, Cortes J. Tyrosine kinase inhibitor-induced platelet dysfunction in patients with chronic myeloid leukemia. Blood 2009;114:261-263. DOI |
 |
Korea Institute of Science and Technology Information
Gwahangno, Yuseong-gu, Daejeon, 305-806, Korea TEL : +82-42-869-1752
Copyright (c) 2009 KISTI. All Rights Reserved. For more information mail to
webmaster
